Cargando…
Clinical significance of concomitant extrahepatic autoimmune disease in patients with autoimmune liver disease
BACKGROUND AND AIM: This study aimed to determine the presence of concomitant extrahepatic autoimmune disease (EAD) in patients with autoimmune liver disease (ALD) and the efficacy of the treatment response of ALD with the presence of any EAD. MATERIALS AND METHODS: Between January 2001 and November...
Autores principales: | Karakaya, Fatih, Oztekin, Sura, Ozturk, Yelda, Kalkan, Cagdas, Melekoglu Ellik, Zeynep, Halil Elhan, Atilla, Soykan, Irfan, Idilman, Ramazan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kare Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138928/ https://www.ncbi.nlm.nih.gov/pubmed/35782890 http://dx.doi.org/10.14744/hf.2020.2020.0028 |
Ejemplares similares
-
CAR T cells for treating autoimmune diseases
por: Blache, Ulrich, et al.
Publicado: (2023) -
Prdm1 Regulates Thymic Epithelial Function To Prevent Autoimmunity
por: Roberts, Natalie A., et al.
Publicado: (2017) -
Interferon signature in systemic autoimmune diseases: what does it mean?
por: Nocturne, Gaetane, et al.
Publicado: (2022) -
Prolidase Deficiency Causes Spontaneous T Cell Activation and Lupus-like Autoimmunity
por: Hodgson, Rose, et al.
Publicado: (2023) -
Tolerance and efficacy of targeted therapies prescribed for off-label indications in refractory systemic autoimmune diseases: data of the first 100 patients enrolled in the TATA registry (TArgeted Therapy in Autoimmune Diseases)
por: Gottenberg, Jacques-Eric, et al.
Publicado: (2022)